| 101 |
22614869 | Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. | 2012 Aug |
3 |
| 102 |
22701315 | Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs. | 2012 |
1 |
| 103 |
22989452 | [Effect of Src tyrosine kinase inhibition on the drug-resistance as well as MDR1 and LRP expression of the human cis-platinum-resistant lung cancer cell line A549/DDP]. | 2012 Sep |
2 |
| 104 |
23038675 | Possible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells. | 2012 Dec |
1 |
| 105 |
23152886 | Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells. | 2012 |
1 |
| 106 |
20627363 | Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. | 2011 Feb |
2 |
| 107 |
20856196 | Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. | 2011 Jan 27 |
1 |
| 108 |
21325069 | Identification of loss of p16 expression and upregulation of MDR-1 as genetic events resulting from two novel chromosomal translocations found in a plasmablastic lymphoma of the uterus. | 2011 Apr 15 |
1 |
| 109 |
21332314 | Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer. | 2011 Feb |
1 |
| 110 |
21805041 | Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines. | 2011 Nov |
1 |
| 111 |
19875192 | Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy. | 2010 Jul |
1 |
| 112 |
20168208 | Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells. | 2010 Jun |
1 |
| 113 |
20189873 | Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients. | 2010 Mar |
1 |
| 114 |
20458768 | Establishment of a human hepatoma multidrug resistant cell line in vitro. | 2010 May 14 |
1 |
| 115 |
20628484 | Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line. | 2010 |
2 |
| 116 |
20689757 | MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. | 2010 Aug |
2 |
| 117 |
20944142 | Down-regulation of P-glycoprotein is associated with resistance to cisplatin and VP-16 in human lung cancer cell lines. | 2010 Sep |
4 |
| 118 |
18812689 | MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer. | 2009 |
2 |
| 119 |
19733628 | Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy. | 2009 Nov 6 |
2 |
| 120 |
19900859 | Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival. | 2009 Nov |
1 |
| 121 |
18809583 | Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. | 2008 Dec |
1 |
| 122 |
19000447 | [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues]. | 2008 Nov |
2 |
| 123 |
17190787 | Characteristic expression of Lewis-antigenic glycolipids in human ovarian carcinoma-derived cells with anticancer drug-resistance. | 2007 Mar |
1 |
| 124 |
17374987 | Using attenuated Salmonella typhi as tumor targeting vector for MDR1 siRNA delivery. | 2007 Apr |
2 |
| 125 |
17611393 | Bridge linkage role played by CD98hc of anti-tumor drug resistance and cancer metastasis on cisplatin-resistant ovarian cancer cells. | 2007 Jun |
1 |
| 126 |
18231753 | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 2007 Dec |
1 |
| 127 |
16478794 | MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer. | 2006 Mar |
2 |
| 128 |
16995873 | Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. | 2006 Dec |
1 |
| 129 |
15643508 | Bcl-2 overexpression enhances in vitro sensitivity against docetaxel in non-small cell lung cancer. | 2005 Feb |
2 |
| 130 |
15650019 | The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. | 2005 May |
2 |
| 131 |
16026610 | Cancer cell adaptation to chemotherapy. | 2005 Jul 18 |
3 |
| 132 |
14726695 | Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein. | 2004 Apr |
1 |
| 133 |
15262121 | The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model. | 2004 Jul |
3 |
| 134 |
15517878 | Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15. | 2004 Sep-Oct |
2 |
| 135 |
16107775 | MDR1, MRP1 and MRP2 genotypes and in vitro chemosensitivity in Japanese patients with colorectal adenocarcinomas. | 2004 |
3 |
| 136 |
12528803 | Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines. | 2003 |
1 |
| 137 |
14671431 | The farnesyl protein transferase inhibitor lonafarnib (SCH66336) is an inhibitor of multidrug resistance proteins 1 and 2. | 2003 Dec |
1 |
| 138 |
12142085 | The gain of function of the p53 mutant Asp281Gly is dependent on its ability to form tetramers. | 2002 Nov 8 |
1 |
| 139 |
12365029 | The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model. | 2002 Oct 15 |
1 |
| 140 |
12370750 | Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene. | 2002 Nov |
1 |
| 141 |
12403069 | MDR1 up-regulated by apoptotic stimuli suppresses apoptotic signaling. | 2002 Sep |
3 |
| 142 |
11500053 | Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression. | 2001 Aug 17 |
1 |
| 143 |
11745426 | Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin. | 2001 Nov 1 |
2 |
| 144 |
14994074 | [Establishment and biological characteristics of cisplatin resistant cell line from human tongue squamous cell carcinoma Tca8113]. | 2001 Mar |
1 |
| 145 |
10601617 | Clofazimine and B4121 sensitize an intrinsically resistant human colon cancer cell line to P-glycoprotein substrates. | 2000 Jan-Feb |
2 |
| 146 |
10764626 | Low-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution. | 2000 Apr 15 |
1 |
| 147 |
10433011 | Interferon-alpha modulates resistance to cisplatin in three human hepatoma cell lines. | 1999 Jun |
2 |
| 148 |
11817335 | The role of P-glycoprotein in human gastric cancer xenografts in response to chemotherapy. | 1999 |
1 |
| 149 |
9815817 | Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. | 1997 Aug |
1 |
| 150 |
8599869 | Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells. | 1996 |
1 |